Imatinib Pregnancy and Breastfeeding Warnings
Imatinib is also known as: Gleevec
Imatinib Pregnancy Warnings
Imatinib mesylate was teratogenic in rats. Imatinib can cause fetal harm when administered to a pregnant woman. There have been post-market reports of spontaneous abortions and infant congenital anomalies. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. FDA pregnancy category D: There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
FDA pregnancy category: D Use of imatinib is not recommended. Comments: Sexually active female patients of reproductive potential should use highly effective contraception.
Imatinib Breastfeeding Warnings
Imatinib is excreted into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, women should be advised against breast-feeding while taking imatinib.
One case of imatinib concentrations in human milk has been reported. Both imatinib and its main active metabolite, the N-desmethyl derivative (CGP 74588) were extracted from milk and plasma protein. The milk-plasma ratio reached 0.5 for imatinib and 0.9 for CGP 74588.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.